1. Home
  2. PHAR vs SFIX Comparison

PHAR vs SFIX Comparison

Compare PHAR & SFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • SFIX
  • Stock Information
  • Founded
  • PHAR 1988
  • SFIX 2011
  • Country
  • PHAR Netherlands
  • SFIX United States
  • Employees
  • PHAR N/A
  • SFIX N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • SFIX Catalog/Specialty Distribution
  • Sector
  • PHAR Health Care
  • SFIX Consumer Discretionary
  • Exchange
  • PHAR Nasdaq
  • SFIX Nasdaq
  • Market Cap
  • PHAR 731.1M
  • SFIX 482.8M
  • IPO Year
  • PHAR N/A
  • SFIX 2017
  • Fundamental
  • Price
  • PHAR $10.31
  • SFIX $4.31
  • Analyst Decision
  • PHAR Strong Buy
  • SFIX Hold
  • Analyst Count
  • PHAR 3
  • SFIX 3
  • Target Price
  • PHAR $30.00
  • SFIX $5.67
  • AVG Volume (30 Days)
  • PHAR 3.6K
  • SFIX 2.1M
  • Earning Date
  • PHAR 07-31-2025
  • SFIX 06-10-2025
  • Dividend Yield
  • PHAR N/A
  • SFIX N/A
  • EPS Growth
  • PHAR N/A
  • SFIX N/A
  • EPS
  • PHAR N/A
  • SFIX N/A
  • Revenue
  • PHAR $320,708,000.00
  • SFIX $1,275,494,000.00
  • Revenue This Year
  • PHAR $13.31
  • SFIX N/A
  • Revenue Next Year
  • PHAR $7.68
  • SFIX N/A
  • P/E Ratio
  • PHAR N/A
  • SFIX N/A
  • Revenue Growth
  • PHAR 24.13
  • SFIX N/A
  • 52 Week Low
  • PHAR $6.65
  • SFIX $2.21
  • 52 Week High
  • PHAR $12.61
  • SFIX $6.99
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 43.60
  • SFIX 48.27
  • Support Level
  • PHAR $9.99
  • SFIX $3.86
  • Resistance Level
  • PHAR $10.49
  • SFIX $4.30
  • Average True Range (ATR)
  • PHAR 0.34
  • SFIX 0.19
  • MACD
  • PHAR -0.14
  • SFIX 0.03
  • Stochastic Oscillator
  • PHAR 7.45
  • SFIX 54.14

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About SFIX Stitch Fix Inc.

Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.

Share on Social Networks: